Week 282 Review - Superb end to a traumatic year

I was really hoping we wouldn't have a down week at the end of 2020, although it would have probably summed up the year quite well. I needn't have worried, as the final week, despite being very short, was absolutely brilliant.

I went a bit mad too, and cashed in some profits to buy into new things, as well as taking more profits from the trading account.

Fortunately OPTI:Optibiotix Health had a rally over the last few days which accounted for much of this week's rise, but JLP:Jubilee Metals and SBTX:SkinBioTherapeutics also played a big part.

The result was a narrowing of the deficit between cost and value of £12,735, so that deficit now stands at a relatively small £7,729 and the overall portfolio value has hit another milestone, standing at £120,024. That's a very nice way to end the year as it's the highest ever portfolio value. Granted I've added another £30k since my previous record valuation so I have cheated slightly in achieving the record.

Worst performer was a new share ITX:Itaconix which I dipped a little toe in with some SIPP profits to buy 16,297 shares at 3.068p costing £511.94. I like to put a small marker down so I start to follow the story more closely. If I like what I see I may add, else I ditch them. These have a wide spread and dropped a little after I bought them, so they are 16% down already.

FXPO:Ferrexpo have been doing amazingly well recently, but this week they dropped 7%. I suspect a little profit taking and nerves over a blip in the iron ore price. I'm still hoping for a special dividend in January.

My only other big loser was DDDD:4D Pharma which I'm back in now. One of the holdings is my trading account, so the small amount and commission meant that ended the week 7% down on when I bought it. The larger new SIPP holding only dropped 4%.

IES:Invinity Energy has been on a bit of a roll as more contracts are announced. It climbed another 5% this week and is only 55% down now. There may yet be hope of salvaging something from the RED:RedT Energy mess.

OPTI:Optibiotix had a spurt in the last 2 days and climbed 8p which is 13% and accounts for £10k of this week's rise. Could 2021 be the year when this finally takes off?

TRX:Tissue Regenix has climbed a little, but it's showing a 20% improvement. That's because I decided that now the Woodford holding has been mostly sold off, and all the people that panicked have finished selling, this is looking like a reasonable recovery play. I was stuck with an average purchase price of 18p, so this was going to be showing a loss for a long time. I took fairly drastic action and bought 90,594 shares at 0.5464p costing £506.96. That brought my average price down from 18p to 2.26p. I think there's a much better chance of that getting into profit than if I'd kept just the 18p holding. Once Covid settles down and operations start happening again, demand for their products will be high, and although everything went wrong for Woodford, you could argue that his investors just got impatient.

JLP:Jubilee Metals would normally get Share of the Week for a 30% increase, as the meteoric rise continues. I'm expecting a trace back to 12p from today's 12.7p until next news, but I'm hanging onto these long term now as there's so much in the pipeline that it's too dangerous to trade. My holding is now 194% up and making £8,372 potential profit. Happy days.

Share of the Week is SBTX:SkinBioTherapeutics which climbed 40% from a 14% loss to a 26% profit. I treated them quite badly and sold all my trading shares and 30% of my SIPP shares for a small profit to fund my purchases mentioned above. I'm not very good at being disciplined with my SBTX trading, as the reason for it is meant to be so I can buy more on dips, but I keep spending all the proceeds. I still have 15,581 shares though, and they are currently making £696 potential profit.

A joy to behold. The nearest to break-even for over a year, and a stunning recovery from the Covid crash.

What a difference a week makes!

Here's the ISA and share portfolios after week 22 of year 6

			Weekly Change
Cash	£36.70		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£57,952.97	(-8.0%)	+£7,206.02
Potential profits	£8,372.05		+£1,300.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£112.88	(3.2%)	-£5.37
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£339.75	(9.8%)	-£1.21
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Not much activity in this account compared to the others, but JLP:Jubilee Metals put on a 1.3p spurt worth £1,300 and most of the rest of the £7,206 improvement is OPTI:Optibiotix Health narrowing losses.

Still quite a deficit to make up on this one. I'm hoping that IQE:IQE will get to 100p as that will give me £700 profit, which will be enough to write off BLCC:Block Commodities from my portfolio without leaving a big hole in performance. I really want to write off these no-hope shares so I don't have to go through the admin of updating them or even looking at the horrible worthless things.

The gap to make up is just £5,000 and we'll cross the fabled £0 line.

The SIPP looks like this after week 266 overall and week 6 of year 6

			Weekly Change
Cash	£286.44		-£182.45
Portfolio cost	£61,813.33		+£854.42
Portfolio sell value (bid price - commission)	£59,531.72	(-3.7%)	+£5,414.03
Potential profits	£5,579.08		+£595.53
Yr 6 Dividends	£360.50		+£13.88
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£370.59		+£370.59
Yr 6 Average monthly cash profit	£515.97	(15.4%)	+£230.00
Total Dividends	£2,427.58		+£13.88
Total Interest	£0.20		+£0
Total Profit from sales	£15,830.03		+£370.59
Average monthly cash profit	£287.05	(8.6%)	+£5.21
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	44%		+1%

OK - there's a lot going on here so I'll document events chronologically.

First I decided I wanted to buy something with my CAML:Central Asia Metals dividend, but it wasn't quite enough so I added £150. I wanted more gold, and have been watching HUM:Hummingbird Resources for years. They are high risk because of the territory where they operate in Mali and Liberia, but they have been there for over 10 years and are climbing back towards the 40p they were trading at during the summer. I bought 1,538 shares at 32.5p costing £511.50 and I think of them as mostly free as they came (nearly) from the CAML dividend. I doubt I'll hold them long, and will probably re-invest in CAML after selling.

I've discussed the next event near the top of the blog when I massively increased my TRX:Tissue Regenix holding. I got the cash for that by selling 216 CAML:Central Asia Metals shares to liberate £517.59 and make £121.63 (29.8%) profit. It was a bit naughty as I don't want to reduce CAML, but I saw an opportunity to salvage something from my TRX investment and took it.

Next was my naughty top-slice of SBTX:SkinBioTherapeutics. I sold 7,500 shares at 20.705p after paying 17.22p and made £248.96 (19%) profit. This liberated £1,540 which I needed to get back into DDDD:4D Pharma before their Nasdaq listing and the small toe-dip in ITX:Itaconix I described near the start of the blog. 

I bought 769 shares in DDDD:4D Pharma at 130p costing £1,011.65. They did drop back a few pence so I'm down 4% but wanted to be in for the January ride as it could get thrilling and I desperately wanted to keep a long-term holding in this one after my opportunistic profit-taking a few months ago when I made a nice £2,258 profit. This time I want to hold them for the whole adventure.

The the re-investing of dividend, injection and profits caused the cost to go up by £845, but cash went down less thanks to £137.50 tax rebate in my AJ Bell SIPP account. Profits increased by £595 despite the sells and overall value got a big boost from OPTI:Optibiotix Health. Annual performance looks flattering, but it's projected based on the first 6 weeks so won't last, and long term performance ticked up by 0.1% to 8.6%.

We're so, so close to that cost line now.

About £2,200 to make up. Another week like this, or even half as good as this will do the trick.

The trading account looks like this after week 232 overall and week 24 of year 5

			Weekly Change
Cash	£240.85		-£1.05
Portfolio cost	£2,367.41		-£0.14
Portfolio sell value (bid price - commission)	£1,975.59	(-16.6%)	+£115.33
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£565.91		+£98.81
Yr 5 Average monthly cash profit	£104.38	(52.9%)	+£14.08
Dividends	£60.10		+£0
Profit from sales	£852.28		+£98.81
Average monthly cash profit	£17.04	(8.6%)	+£1.78
(Sold stocks profit + Dividends - Fees  / Months)

I sold my SBTX:SkinBioTherapeutics shares at 20.55p making £98.91 (18.8%) profit and liberated another £100 back to my bank account. I'm now trading with a purpose as I'm planning a trip to Madagascar next year and this can contribute to my holiday fund. The sooner my share account OPTI:Optibiotix holding gets into profit the sooner I can transfer that into this pot. as my plan is to at least double up the amount available so there's more chance I can trade something every week.

I re-invested the £500 in DDDD:4D Pharma, buying 383 shares at 130.5p, which are 7% down. However, CAML:Central Asia Metals is only 5% down and OPTI:Optibiotix is only 1% down, so it's possible I will have 3 active pots. I may even use one profit to write off my IQE:IQE loss as it will take them ages to break even and I could be using the pot for something else.

The dip from a few weeks ago is fixed, and the orange line continues to drop. I don't expect this account to ever have the chance to cross the red line.

That will do nicely. an increase despite cashing in £98 profit is great.

Here's my wish list:

1. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operation. Nope, but I'm getting beyond caring.
   
2. OPTI:Optibiotix Health to get within 10% of profit. Yes! This one can now be upgraded to getting back into profit.
3. CMCL:Caledonia Mining reverses the down trend and gets back into profit. Down again this week. I'm really surprised. Good job this is a long term holding, but it's letting down my magic formula shares badly.
   
4.  SBTX:SkinBioTherapeutics gets back into profit. Yes! I can't think of any more wishes for this one yet. I need to work out how to get my 7,500 shares back that I sold. This wish is now retired as complete.
5. The combined portfolios get back into the black. This one is getting close now - will it come true next week or will there be a post-Brexit slump?

2020 has been a very trying year, but the portfolio is in a much better place at the end than it was at the beginning, despite the terrifying crash in March. The big winner in 2020 has been the magic formula trial, with all but one of the shares in profit, and over £2,000 potential profit based on £6,000 investment, and over £200 in dividends. I'm happy this is a great way to pick shares and look forward to February or March when I get my next £2,000 pension transfer to pick another 2, and really looking forward to June when I can start selling the ones I bought last year and realising the profits.

Here's to 2021 where some of my shares could get a chance to really shine.

Week 281 Review - Christmas grinched by Optibiotix dip

Although I'm moaning about being down £600 at the end of the week thanks to a 1p drop for OPTI:Optibiotix Health today, it was looking a lot worse early in the week when I was down £5K. The deficit between cost and value has widened to £20,465 and overall portfolio value dropped to £106,617.

There were no big losers this week, but the winners weren't enough to make up for the deficit from a few big shares losing small amounts.

PAY:Paypoint have been one of the more sluggish magic formula shares, but climbed 5% this week to go up by 11% overall. There are a few potential clouds still over this one, but they are making good profits so I remain hopeful they will continue to rise up to my review date in July 2021.

RDT:Rosslyn Data announced a few contract wins, and it looks like their new software for processing customs forms could be a winner. I'm surprised the shares only climbed 5%. It still leaves them down by 65% in my portfolio.

SAE:Simec Atlantis Energy also rose by 5%. I still worry about these and wouldn't buy them now, but I hold in hope.

FXPO:Ferrexpo have been really motoring lately, possibly in anticipation of a January special dividend, and this week they went up 7% to go 62% up overall and making £632 potential profit.

Share of the Week also rose 7%, but I like CAML:Central Asia Metals more, and their rise was worth a lot more thanks to my big holding. These are now 28% up and making £3,041 potential profit. I won't be selling these though. They are a keeper for the epic dividend.

More flatness

The rise seems to have faltered.

Here's the ISA and share portfolios after week 21 of year 6.

			Weekly Change
Cash	£36.70		-£19.25
Portfolio cost	£63,009.29		+£19.25
Portfolio sell value (bid price-commission)	£50,746.95	(-19.5%)	-£894.46
Potential profits	£7,072.05		-£200.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£118.25	(3.4%)	-£5.91
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£340.96	(9.8%)	-£1.22
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Cash went down by £19 as I was allowed to get 11 IES:Invinity Energy shares in the open offer, which is half what I applied for as it was over subscribed. Much better than the 3 I was allocated though. Potential profits are down £200 after JLP:Jubilee Metals lost 0.2p, but given last week's 34% rise I'm amazed the profit takers didn't do more damage. Value is down by a further £694 courtesy of OPTI:Optibiotix Health losing 1p.

I've finally given up on the statistic of monthly performance compared to cost of portfolio. I've decided it's a pointless stat that's going to get harder to live up to as the cost rises and profits are re-invested. I'm now focusing entirely on the performance compared to the injection amount, as that's what I've put into the pot, and what would have been invested in something else. That's still showing I'm way behind 10% target in year 6 when we're almost at the halfway point, but doing ok long-term.

Nasty little dip.

Getting a bit close to the trend line, but still the right side.

Here's the SIPP after week 265 overall and week 5 of year 6.

			Weekly Change
Cash	£468.89		+£0
Portfolio cost	£60,958.91		+£0
Portfolio sell value (bid price - commission)	£53,263.27	(-12.6%)	+£289.92
Potential profits	£4,983.55		+£921.87
Yr 6 Dividends	£346.62		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	£285.97	(8.6%)	-£71.49
Total Dividends	£2,413.70		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£281.84	(8.5%)	-£1.07
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	43%		+0%

This account improved in value thanks to a socking great £921 increase in potential profits from the likes of CAML:Central Asia Metals and FXPO:Ferrexpo. That made up for the OPTI:Optibiotix Health drop and a bit more. Year 6 performance is still a bit mad as the amount is based on the projection of what we've had in the first 5 weeks, which included the huge CAML dividend. Long term performance still needs a boost, and the only thing that can provide that is if I trade SBTX:SkinBioTherapeutics. In May we'll get a much bigger boost as I start reviewing and selling the magic formula shares.

The increase was so small it looks flat

Still unable to get into that buffer zone.

Here's the trading portfolio after week 231 overall and week 23 of year 5

			Weekly Change
Cash	£241.90		+£0
Portfolio cost	£2,367.55		+£0
Portfolio sell value (bid price - commission)	£1,860.26	(-21.4%)	+£3.55
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£467.10		+£0
Yr 5 Average monthly cash profit	£90.30	(45.8%)	-£4.10
Dividends	£60.10		+£0
Profit from sales	£753.47		+£0
Average monthly cash profit	£15.26	(7.7%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

Couldn't get much more flat really. This one will carry on monitoring performance based on cost, as the cost will never go above around £2,500 unless new £500 increments are made. Key thing is that three of the five stocks are in a position where I may be able to sell them soon, so things could start getting exciting.

I like this chart!

The steep slope is getting steeper.

Here's my wish list:

1. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operation. I'm staggered this hasn't been announced yet, but still we wait.
   
2. OPTI:Optibiotix Health to get within 10% of profit. Second week in a row it has dropped by a penny.
3. CMCL:Caledonia Mining reverses the down trend and gets back into profit. Flat this week. At least it's not a drop. The spread has been stupidly high for a share that also trades on NY Stock Exchange.
   
4.  SBTX:SkinBioTherapeutics gets back into profit. Still falling. Terribly frustrating, but can't go on forever.
5. The combined portfolios get back into the black. A blip downwards this week, but there's some good progress and don't forget I'm sitting on £12,000 un-banked profits at the moment.Normally I'd be cashing these in, but not this time. I'm determined to let them ride.
   

Week 280 Review - A flat week but Jubilee Metals continues to soar

This week was the flattest I can remember for a long time, with some great rises counter-acted by a 1p drop in OPTI:Optibiotix Health which spoiled the Christmas cheer. At least it was another up week, gaining £200 and narrowing the deficit between cost and value to £19,864.28, with total value plus cash at £107,218.

Although OPTI:Optibiotix Health only dropped 1p, I bought some in my trading account when they were up on the week, so they ended up down 13% compared to my main holding only dropping 2%. My first attempt to trade OPTI has started very badly.

All good news from there, with APAX:Apax Global Alpha continuing the great form of the magic formula shares climbing 11% to go 32% up altogether and making £319 potential profit. These are due for review in June 2021 and have also paid £33 dividend. I'm thinking I should trash everything else I do and stick to the magic formula!

ITV:ITV are another magic formula share and climbed 14% this week to go an amazing 50% up and making £509 potential profit. If these would just re-instate the dividend I'll be very happy, as without a dividend they wouldn't have qualified for my magic formula list. I was ranking them on last year's dividend.

JLP:Jubilee Metals recovered from last week's profit taking and soared 32% to win Share of the Week. They are now up 168% and making £7,272 potential profit. I must stay strong and hold them!

That illustrates flatness quite well.

I just can't seem to narrow that loss below £20K. It's like a big impenetrable buffer.

The ISA and share accounts look like this

			Weekly Change
Cash	£55.95		+£0
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£51,622.16	(-18.0%)	+£568.06
Potential profits	£7,272.05		+£1,400.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£124.16	(2.4%)	-£6.54
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£342.18	(6.5%)	-£1.22
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	9.8%		-0.1%
Compound performance	53%		+0%

JLP:Jubilee Metals potential profits are up by a staggering £1,400 but that's savaged by the drop in OPTI:Optibiotix Health to a more modest £568 increase. Long term performance drops another 0.1% to go 0.2% below target.

The rise is hardly visible

Still dragging the trend line higher

The SIPP looks like this after week 264

			Weekly Change
Cash	£468.89		+£0
Portfolio cost	£60,958.91		+£0
Portfolio sell value (bid price - commission)	£52,973.35	(-13.1%)	-£259.15
Potential profits	£4,061.68		+£319.41
Yr 6 Dividends	£346.62		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	£357.46	(7.0%)	-£119.15
Total Dividends	£2,413.70		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£282.91	(5.6%)	-£1.08
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.5%		+0%
Compound performance	43%		+0%

Nice increase in potential profit of £319 among the magic formula shares, but CAML:Central Asia Metals was completely flat, so the drop in OPTI:Optibiotix Health meant a loss of £259 for the week. Year 6 performance is being dragged back to reality after a crazy start caused by the big CAML dividend.

Still quite close to that red line!

Again there's that impenetrable buffer

The trading account looks like this after week 230

			Weekly Change
Cash	£241.90		-£6.46
Portfolio cost	£2,367.55		+£13.44
Portfolio sell value (bid price - commission)	£1,856.71	(-21.6%)	-£108.64
Potential profits	£0		-£39.12
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£467.10		+£96.98
Yr 5 Average monthly cash profit	£94.90	(47.8%)	+£15.51
Dividends	£60.10		+£0
Profit from sales	£753.47		+£96.98
Average monthly cash profit	£15.33	(7.8%)	+£1.77
(Sold stocks profit + Dividends - Fees  / Months)

I sold my 168 shares in TRMR:Tremor for 361.44p after buying them for 289.49p making a profit of £96.98 (19%). They ended the week at 330p so for once my timing was OK. I re-invested in OPTI:Optibiotix Health thinking there's no way they are going lower than 55p so let's try trading them. By the end of today I could have bought them for 52p but instead I bought 912 at 54.8p costing £511.73. They dropped 13% in a day when you include spread and commission.

My year 5 performance is looking amazing at 47% when we're only half way through the year. If I don't sell anything for the next 6 months I'll still end up with profits of 20%. My long term performance improved by just £1.77, but it is now 7.8%, which although below target is quite good.

CAML:Central Asia Metals is only 11% down now and has some strong upward momentum, and we know how fast both SBTX:SkinBioTherapeutics and OPTI:Optibiotix Health can climb when they want to, and both of these were bought very cheap despite being down at the moment.

A big dip, but that's what you get when you take profits. The injection line also dips as I removed £90 into my bank account for a fine malt whisky at Christmas.

A steep drop as we see the effect of both profit taking and OPTI:Optibiotix Health's big fall, but the trend line is still steepening upwards.

Here's my wish list:

1. TLOU:Tlou Energy announce de-watering has resumed. I'm going to remove this wish, as there was an update today which spoke of progress but also delays. Gas is flowing, but de-watering will not resume until more wells are dug. That's going to be some time so I don't want to keep wishing every week when I know it's not coming any time soon.
   
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Incredibly there's still no news, but the share price continues to rise so it's a bit academic. I'm still keeping the wish as it should be very soon.
   
3. OPTI:Optibiotix to get within 10% of profit. Still possible before Christmas but increasingly unlikely without news..
4. CMCL:Caledonia Mining reverses the down trend and gets back into profit. They were up a little this week, but I expected more after news of 2 exploration deals. I really don't understand this big drop, but I'm convinced the turn around is very close.
   
5.  SBTX:SkinBioTherapeutics gets back into profit. Nope, still falling which is very disappointing as I thought it could get back to 20p.
6. The combined portfolios get back into the black. Going n the right direction, but £200 a week is going to take a very long time..

Week 279 Review - Solid week and big Central Asia Metals dividend

A pretty good week, but some big fallers for the first time in a while. The portfolio value increased by £3,826 and reduced the deficit between cost and value to £20,064. Total portfolio value increased to £107,011 which is the best for a very long time.

Biggest loser was TRMR:Tremor dropping 9%, which isn't a surprise after last week's 46% rise as profit taking set in. I was hoping to sell during the week, but I'm only 8% up now, and I think this will return to the 21% gain I need to be able to bank £100.

SAE:Simec Atlantis Energy dropped 8% after revealing planning consents for the Uskmouth power station conversion were delayed due to more information having been requested. I don't hold out much hope for a rapid recovery, and these are down by 76% now.

ITV:ITV has had a great few weeks, but stalled this week and dropped 7%. They are still up by 36% and I really hope they feel able to re-instate the dividend.

JLP:Jubilee Metals suffered the same fate as TRMR:Tremor following last week's 51% rise. Profit takers piled in and the price dropped by 7%. I'm still holding long and strong for 40p and dividends, especially as after the drop my holding is still up 136% and the only patch of green in my ISA.

TLOU:Tlou Energy have been lacking news lately and the big buyer has dried up, so they drifted another 7% this week to go 59% down.

OPTI:Optibiotix crept up 3p from the recent lows which is 5% and around £3,350 of this week's rise. My ISA holding is still 18% down and my SIPP 21% down. I did make a decision during the week. I retained an OPTI purchase of £2,593 in my share account. It was meant to be to pay for a big holiday in Antarctica but that's going to be so expensive if it ever happens that I'll need more substantial funding than this. I thought about bedding it in my ISA, but I had a better idea. Once it gets into profit I'll gradually sell it off, liberating £500 each time. I'll then move the £500 to my trading account and effectively double the size and make it more likely that I'll have something ready to sell each week. Then I'll be satisfied with smaller gains, which has been the problem with me not flogging TRMR:Tremor when it got to £80 profit, which should have been plenty on a £500 investment. The only question is how long it will take for OPTI to get back in profit!

BLU:Blue Star Capital has been quite volatile lately. It climbed 6% this week but is still 74% down. There is still a glimmer of hope this will come good, but I still regard it as a mistake.

CAML:Central Asia Metals is justifying its position as my best-run company this week. Not only a 6% rise taking it up by 22% with £2,290 potential profit, but they paid out a £346 dividend taking my total dividend earnings from this company to £1,877. Although it's one of my magic formula shares, I'm not treating it as such, in that I won't review after 12 months and sell if it's not in the top 30 any more. I'll keep them until the inevitable buy-out.

POLR:Polar Capital Holdings have been going really great recently, and climbed another 6% this week to go 30% up and making £295 potential profits as well as £49 dividends so far. Review date for these is 23rd June.

Share of the Week is FXPO:Ferrexpo which has been responding really well to the increasing price of iron ore and China saying they are going to stop buying from Australia. They climbed 8% this week to go 51% up overall and making £513 potential profit and £65 dividends. Last January they announced a special dividend, which would be nice if they do so again.

We're closer to the cost line than the injection line for the first time in a while.

Not quite up as close to breaking even as on three other occasions this year, but moving in the right direction. Let's hope a no-deal Brexit won't ruin all that.

Here's the ISA and share portfolios

			Weekly Change
Cash	£55.95		+£50.00
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£51,054.10	(-18.9%)	+£1,721.09
Potential profits	£5,872.05		-£300.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£130.70	(2.5%)	-£7.26
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£343.40	(6.5%)	-£1.24
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	9.9%		+0%
Compound performance	53%		+0%

Cash rose by £50 as I added some to pay for the IES:Invinity Energy open offer. In theory I'm only entitled to 3 shares, but have applied for 22 in the hope I can get to a nice round holding of 250 shares. These seem to have some momentum behind them after the merger so I'm happy to try and get a few more at 175p when the current offer price is 200p.

Potential profits slipped by £300 as JLP:Jubilee Metals lost 0.3p. It's nice and easy to calculate when you have 100,000 shares. Long term performance is still pretty good at 9.9% of injection amount per month.

Still nearer the injection line than the cost line with this one

As with the overall chart, this one is near the top of the performance metric for the last 12 months, but not quite above it.

Here's the SIPP after week 263

			Weekly Change
Cash	£468.89		+£346.62
Portfolio cost	£60,958.91		+£0
Portfolio sell value (bid price - commission)	£53,232.50	(-12.7%)	+£2,133.73
Potential profits	£3,742.27		+£617.64
Yr 6 Dividends	£346.62		+£346.62
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	£476.61	(9.4%)	+£512.70
Total Dividends	£2,413.70		+£346.62
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£283.99	(5.6%)	+£4.65
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.5%		+0.1%
Compound performance	43%		+1%

The CAML:Central Asia Metals dividend of £346 rescued my negative year 6 performance stats, although they look a bit wild as we're only on week 3 to they are projecting an unrealistic performance. Long term performance did tick up by 0.1% and compound performance by 1%. Potential profits climbed by a healthy £617.

This one is most definitely closer to the cost line than the injection line and looking great.

Interesting that although the first chart looks really good for this one, the performance chart is more revealing. We're actually further away form break-even compared to earlier in the year than the other accounts are. The other chart is flattered by multiple injections and tax rebates. This shows we have a way to go before improving on even the recent peaks.

The trading account looks like this after week 229

			Weekly Change
Cash	£248.36		+£12.18
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,951.91	(-17.1%)	-£28.32
Potential profits	£39.12		-£43.68
Year 5 Dividends	£12.18		+£12.18
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£78.89	(40.2%)	-£1.30
Dividends	£60.10		+£12.18
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.56	(6.9%)	+£0.17
(Sold stocks profit + Dividends - Fees  / Months)

It's a sign of a failing trading account when you get £12 dividend. This was from CAML:Central Asia Metals, and my purchase of that was so badly timed I've now had £54 dividends from them in this account. They are only 11% down now, so hopefully I won't have to keep them in here for much longer.

The drop in TRMR:Tremor took away £43 potential profit, but improvements elsewhere meant the value only dropped by £28. I really hope I get to sell TRMR next week.

A little blip on this beautiful chart

So close to break even now. It's a hell of a turnaround in just a few weeks.

Here's my wish list

1. TLOU:Tlou Energy announce de-watering has resumed. The price is dropping back now and the silence is a little worrying.
   
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Still nothing. I'm amazed we haven't heard anything yet. Hopefully they are planning it as a Christmas present.
   
3. OPTI:Optibiotix to get within 10% of profit. Back on the cards now and potentially achievable before christmas.
4. CMCL:Caledonia Mining reverses the down trend and gets back into profit. Nope. The price dropped 3% this week despite news that they are planning to explore a new area. That would normally cause a little tick up in the price, so I don't know what's going on here. This is my only negative magic formula share now.
   
5.  SBTX:SkinBioTherapeutics gets back into profit. Same story here. There was a 2% drop this week, but we're still only 9% down, so it could be reversed very quickly.
6. The combined portfolios get back into the black. This is getting closer. The £20K deficit could be gone before the end of January unless Brexit spoils everything.
   

Week 278 Review - Fantastic week despite Optibiotix trying to spoil it

This was one of the best weeks ever for the majority of my shares, but OPTI:Optibiotix tried its hardest to spoil things by dropping 2p. Normally that would have guaranteed a big loss for the week, but not this week as everything else performed so well and we ended up with the deficit between cost and value decreasing by £1,428. That reduced the deficit to £23,891 and total value increased to £102,412, although that includes a £2,000 pension transfer.

For the second week in a row there were no drops of 5% or more.

IQE:IQE continued their gradual improvement with a 6% rise, so amazingly my ISA holding is only down by 8%. I'd love to be able to sell this and move it to SBTX:SkinBioTherapeutics or DDDD:4D Pharma while both are still bargains.

CMCL:Caledonia Mining is my only magic formula share losing money, but had a reversal of fortune this week to climb by 7%. They are still 18% down but hugely undervalued, so I'm confident they will soon join the others in profit.

CAML:Central Asia Metals has been recovering really well after the selling pressure from a large institutional investor stopped and the price of copper started rising. They climbed another 8% this week to go 16% up and making £1,712 potential profit. So glad I bought loads ore of these when they were so cheap. Big dividend coming soon too.

ITV:ITV have been superb ever since I bought them. Another 9% rise this week sees them up by 43% and making £438 potential profit. I have to hold these until October next year if I stick with the magic formula rule of holding for at least a year. Just hoping for a reinstatement of the dividend now.

FXPO:Ferrexpo had a rocky start and are still a bit high risk, but this week soared by 30% to go 43% in the black and making £434 potential profits, along with £65 dividends so far. In previous years they have declared a special dividend in January. I get to review these next May so may be able to realise some profit if they keep going this well.

Normally a 30% rise would have got FXPO:Ferrexpo Share of the Week, but not this week. Even TRMR:Tremor doesn't win it with a massive 46% rise in my trading account. Stellar results led to the long-awaited re-rate and my holding is now up by 17% and making £82 potential profit. I'm really hoping this will go up to my target 367.5p which is another 14.5p. That gives me £100 to take out into my bank account.

Share of the Week is JLP:Jubilee Metals, which climbed a staggering 51% as the market finally sees how much revenue they can make. My holding is now up by 143% and making £6,172 potential profit. I think the momentum will continue here, so I'm holding out for 40p and a 5% dividend of 2p a share which would be a handy income of £2,000 a year. I suspect the company will be bought out before I get the chance, but you never know.

The rise has been made to look better than it was due to a pension injection.

This is more accurate - a small tick upwards staying just above the trend line.

The ISA and share portfolios look like this

			Weekly Change
Cash	£5.95		-£3.75
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£49,333.01	(-21.7%)	+£900.53
Potential profits	£6,172.05		+£2,200.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£137.96	(2.6%)	-£9.07
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£344.64	(6.6%)	-£1.30
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	9.9%		+0%
Compound performance	53%		+0%

Absolutely fantastic increase in JLP:Jubilee Metals potential profits of £2,200, but the overall value only rose by £900 thanks to OPTI:Optibiotix dropping 2p. Cash dropped by the monthly ISA fee. It's so painfully tempting to liberate over £10K to play with, but I have to hold JLP:Jubilee Metals long term. I top sliced a few weeks ago to make my £835 profit. If I'd held them I would have made £2,563. Never mind eh.

Hardly any change despite all the excitement.

As with the combined account, just staying above the trend line.

The SIPP looks like this after week 262

			Weekly Change
Cash	£122.27		-£16.38
Portfolio cost	£60,958.91		+£1,999.72
Portfolio sell value (bid price - commission)	£51,098.77	(-16.2%)	+£250.18
Potential profits	£3,124.63		+£1,277.00
Yr 6 Dividends	£0		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	£-36.09	(-0.7%)	-£36.09
Total Dividends	£2,067.08		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£279.34	(5.5%)	-£1.34
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.4%		-0.5%
Compound performance	42%		-3%

Cash dropped by the monthly fee minus some change after the £2,000 transfer and £1,999.72 spent on 3,868 more OPTI:Optibiotix shares at the crazy bargain price of 51.39p. Potential profits soared by £1,277 but the drop in OPTI wiped out most of that and left a rise of just £250.

The injection hit my long term performance as it's compared to the injection amount. Long term monthly profit dropped 0.5% to 8.4% and compound performance dropped 3% to 42%.

As is traditional, I will report on my current OPTI:Optibiotix holding after my latest purchase. I now have 127,106 shares costing £80,714.75. That works out at 63.5p a share when you count commission, but I usually calculate price before commission, which gives 63.14p a share. They are only worth 48p now so I'm down by £19,739 which causes me rather a lot of frustration. One day this will become spectacularly exciting. It had better be after 5 years of holding at a loss, apart from when I could have made £40K profit if I had sold. I could stand being patient if it wasn't for the memory of the misery of sitting and watching that profit vanish before my eyes.

An over-exaggerated rise due to the injection.

A more realistic rise hardly reducing the deficit at all.

The trading account looks like this after week 228

			Weekly Change
Cash	£236.18		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,980.73	(-15.9%)	+£277.92
Potential profits	£82.80		+£82.80
Year 5 Dividends	£0		+£0
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£80.19	(40.9%)	-£4.22
Dividends	£47.92		+£0
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.39	(6.8%)	-£0.06
(Sold stocks profit + Dividends - Fees  / Months)

A staggering rise of £277.92, as nearly everything climbed and nothing fell. TRMR:Tremor soared to £82 potential profit, and all being well I can get that over £100 and sell nest week. I can actually start thinking about buying something new again! With SBTX:SkinBioTherapeutics only 8% down and CAML:Central Asia Metals only 15% down, this account could get quite lively.

The nice thing about these charts is that I know I'll be able to see that rise for the next 12 months even if it drops again, and it will always make me happy.

Absolutely tore the trend line apart. Just a few hundred quid from break even, although this account is designed to be below break even most of the time as profits are taken too quickly to be in the black.

Let's look at the wish list

Here's my wish list

1. TLOU:Tlou Energy announce de-watering has resumed. Still nothing, and the price was static this week so I think whoever was building a stake has stopped. Maybe next week.
   
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Well, the fact the share price can motor without this news makes me wonder whether it's priced in or if the news will give it even more momentum.
   
3. OPTI:Optibiotix to get within 10% of profit. The opposite seems to be happening ever since I established this wish.
4. CMCL:Caledonia Mining reverses the down trend and gets back into profit. The down trend has been reversed so we're halfway there. I think it will be a few more weeks until this comes true though.
   
5.  SBTX:SkinBioTherapeutics gets back into profit. At least there was no drop this week. I need it to get to 21p to sell my trading pot and it's at 16p, so I suspect not likely next week, but I can dream.
   

So is this what they call the Santa Rally? I've never experienced one before as December has generally been rubbish. This December has started very nicely with the broader portfolio doing very well, in particular the magic formula shares, although I guess I was lucky with timing getting them at the Covid lows. If OPTI:Optibiotix can just wake up, then we may get the combined portfolios back in the black. That should be added to my wish list I think, as it's becoming achievable.